Related Experiment Video
Updated: Jun 19, 2025
06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.5K
The Evolution of Genetic Variability at the LRRK2 Locus.
Dylan T Guenther1, Jordan Follett1, Rim Amouri2
1Department of Neurology, University of Florida, Gainesville, FL 32610, USA.
Genes
|July 27, 2024
Summary
The G2019S mutation in Leucine-rich repeat kinase 2 (LRRK2) is a common cause of Parkinson's disease (PD). This study investigates the mutation's origins, age, and its link to disease onset, suggesting positive selection.
Area of Science:
- Genetics
- Neuroscience
- Immunology
Background:
- Leucine-rich repeat kinase 2 (LRRK2) G2019S mutation is a significant genetic cause of Parkinson's disease (PD), particularly prevalent in Tunisian Arab-Berber populations (>30%).
- LRRK2 plays a role in immune system functions, and its kinase activity may offer a survival advantage against infections, as suggested by animal models.
Purpose of the Study:
- To analyze haplotype variability around the LRRRK2 c.6055G>A (G2019S) mutation.
- To determine the age of the pathogenic LRRRK2 G2019S allele.
- To investigate the relationship between the LRRRK2 G2019S mutation and age of disease onset (AOO) in Parkinson's disease.
- To provide evidence for the positive selection of the LRRRK2 G2019S pathogenic allele.
Main Methods:
- Haplotype analysis of LRRRK2 c.6055G>A (G2019S) mutation.
- Phylogenetic analysis to estimate the age of the pathogenic allele.
- Statistical analysis to correlate mutation presence with age of disease onset.
- Population genetics methods to assess evidence for positive selection.
Main Results:
- Detailed haplotype variability (cis and trans) of the LRRRK2 G2019S mutation was assessed.
- The age of the pathogenic LRRRK2 G2019S allele was defined.
- A relationship between the LRRRK2 G2019S mutation and age of disease onset was explored.
- Evidence supporting the positive selection of the LRRRK2 G2019S pathogenic allele was found.
Conclusions:
- The LRRRK2 G2019S mutation, a frequent cause of Parkinson's disease, exhibits specific haplotype patterns and an estimated age.
- The study provides evidence for a link between this mutation and age of disease onset.
- Findings suggest that the LRRRK2 G2019S pathogenic allele has undergone positive selection, potentially due to its conferred advantages.
More Related Videos
Related Concept Videos
02:05Gene Evolution - Fast or Slow?
7.1K
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
In contrast, regions which code...
7.1K
01:09Mutation, Gene Flow, and Genetic Drift
58.3K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
58.3K
02:32Exon Recombination
3.6K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.6K
01:05Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
02:26Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
01:43Incomplete Dominance
22.3K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
22.3K